BioWorld

Nov. 17, 2005

View Archived Issues

Roche Pays Gilead $62.5M To Settle Tamiflu Dispute

To more quickly "address [the] global public health need" of a vaccine against the avian flu, Gilead Sciences Inc. and F. Hoffmann-La Roche Ltd. are ending their dispute over Tamiflu, and $62.5 million is changing hands. (BioWorld Today) Read More

American BioScience Licenses Japanese Rights To Abraxane

Read More

Human Channelopathy Project Tackling Epilepsy's Complexity

Read More

OncoMethylome Teaming Up With Schering-Plough

Read More

Other News To Note

Read More